Our Metabolic Disease Probiotic Research Services
Six complementary research workstreams, structured around disease biology rather than a one-size-fits-all probiotic pipeline.
Our metabolic disease probiotic research support connects experimental scope to actionable development decisions. Each module can be selected independently or combined into a program-specific research plan, with the biological question and intended evidence package determining the study sequence.
Indication Stratification & Translational Study Design
We define a research hypothesis for the relevant phenotype—adiposity, glucose handling, hepatic lipid burden, renal-metabolic interactions, or appetite-related change. Study plans distinguish exploratory biomarker work from efficacy-oriented experiments and specify appropriate comparators, confounders, biological replicates, and a prespecified analysis plan.
Outputs: indication-specific study matrix, model rationale, endpoint hierarchy, and decision criteria.
Candidate Strain & Functional Phenotype Screening
Candidate microorganisms are evaluated for properties that may matter to the target gut–host pathway, including viable growth, survival in simulated intestinal conditions, substrate utilization, metabolite production, and relevant functional responses. Where useful, controlled co-culture and epithelial assays assess whether a signal remains consistent across matrices and environmental conditions.
Outputs: ranked candidate profiles, functional assay summaries, and a reproducible short list.
Host–Microbe & Barrier Mechanism Assessment
Mechanism-focused work explores epithelial integrity, inflammatory signaling, microbial products, and host–microbe interactions using context-appropriate in vitro systems. We distinguish changes in biomarkers from established causal effects and design follow-up experiments to examine whether candidate activity plausibly connects to insulin resistance, adipose inflammation, or gut–liver communication.
Outputs: host-response assay data, mechanism hypotheses, and validation recommendations.
Phenotype-Guided Preclinical Research Planning
For obesity and glycemic programs, readouts can include body composition, glucose tolerance, insulin-related markers, food intake, and lipid metabolism. Liver-focused programs may prioritize hepatic lipid burden, liver enzymes, and tissue histology; other indications require different organ-specific panels. We align measurement timing, specimens, and controls with the selected disease context.
Outputs: model-specific endpoint map, sampling timetable, and assay-ready sample plan.
Microbiome & Metabolite Mechanism Integration
Microbial community shifts, targeted metabolites, host markers, and pathway-level datasets can be interpreted together to investigate plausible routes of activity. Analytical designs consider short-chain fatty acids, bile-acid-related signals, lipid metabolites, and broader metabolic profiles as scientifically justified, without treating association alone as proof of a mechanism.
Outputs: linked biomarker tables, integrated pathway interpretation, and MoA follow-up priorities.
Cross-Study Interpretation & Candidate Decisions
A candidate can improve one marker while leaving the main metabolic phenotype unchanged. We organize evidence around primary endpoints, reproducibility, sample quality, and biological relevance to compare candidates fairly. The result is a transparent recommendation for confirmatory testing, study redesign, or deprioritization—not an unsupported therapeutic efficacy claim.
Outputs: integrated technical report, key figures and tables, limitations, and next-step decision memo.